Literature DB >> 11892977

Reliable individual change scores on the 3MS in older persons with dementia: results from the Canadian Study of Health and Aging.

J A Correa1, A Perrault, C Wolfson.   

Abstract

We examined the degree of interrater agreement on the Modified Mini-Mental State Examination (3MS), administered both in the home and at the clinical examination, to determine the boundaries of reliable individual changes for 257 community-dwelling older persons who received a diagnosis of dementia at CSHA-1. Individual score differences were approximately normally distributed (mean of differences 0.2; SD 8.0; 95% confidence interval -16 to 16). The intraclass correlation coefficient was 0.85. Except for the language of testing, there was no relationship between score differences and the determinants investigated (i.e., age, education, type and severity of dementia). This study provides evidence that, in a time frame compatible with no change in cognition, the discrepancy between repeat 3MS scores can be as large as +/- 16. These limits represent the range of variability consistent with no change and should be considered when interpreting individual change scores.

Entities:  

Mesh:

Year:  2001        PMID: 11892977     DOI: 10.1017/s1041610202008001

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  2 in total

Review 1.  A review of screening tests for cognitive impairment.

Authors:  Breda Cullen; Brian O'Neill; Jonathan J Evans; Robert F Coen; Brian A Lawlor
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-12-18       Impact factor: 10.154

2.  Effect of central nervous system medication use on decline in cognition in community-dwelling older adults: findings from the Health, Aging And Body Composition Study.

Authors:  Rollin M Wright; Yazan F Roumani; Robert Boudreau; Anne B Newman; Christine M Ruby; Stephanie A Studenski; Ronald I Shorr; Douglas C Bauer; Eleanor M Simonsick; Sarah N Hilmer; Joseph T Hanlon
Journal:  J Am Geriatr Soc       Date:  2009-02       Impact factor: 5.562

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.